1. Bioorg Med Chem Lett. 2006 Sep 15;16(18):4917-21. doi: 
10.1016/j.bmcl.2006.06.055. Epub 2006 Jul 7.

Tetrahydroisoquinolines as MCH-R1 antagonists.

Sasikumar TK(1), Qiang L, Wu WL, Burnett DA, Greenlee WJ, O'Neill K, Hawes BE, 
van Heek M, Graziano M.

Author information:
(1)Schering-Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, NJ 
07033, USA. thavalakulamgar.sasikumar@spcorp.com

A series of potent and selective inhibitors of h-MCH-R1 has been developed based 
on the piperidine glycineamide compounds I and II. These structurally more rigid 
tetrahydroisoquinolines (III and IV) showed better pharmacokinetics. The highly 
potent compounds 12d and 12g displayed excellent rat pk.

DOI: 10.1016/j.bmcl.2006.06.055
PMID: 16824753 [Indexed for MEDLINE]
